ID: ALA5197860

Max Phase: Preclinical

Molecular Formula: C26H40O2

Molecular Weight: 384.60

Associated Items:

Representations

Canonical SMILES:  CC(=C/C=C/C(C)=C/C(=O)O)/C=C1\CCCC(CCC(C)C)=C1CCC(C)C

Standard InChI:  InChI=1S/C26H40O2/c1-19(2)13-15-23-11-8-12-24(25(23)16-14-20(3)4)17-21(5)9-7-10-22(6)18-26(27)28/h7,9-10,17-20H,8,11-16H2,1-6H3,(H,27,28)/b10-7+,21-9-,22-18+,24-17+

Standard InChI Key:  SXJCTSSRCWXFCW-XGDCXREESA-N

Associated Targets(Human)

Retinoid X receptor alpha 3637 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 384.60Molecular Weight (Monoisotopic): 384.3028AlogP: 7.80#Rotatable Bonds: 10
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.56CX Basic pKa: CX LogP: 7.47CX LogD: 4.71
Aromatic Rings: 0Heavy Atoms: 28QED Weighted: 0.31Np Likeness Score: 1.25

References

1. Atigadda VR, Kashyap MP, Yang Z, Chattopadhyay D, Melo N, Sinha R, Belyaeva OV, Chou CF, Chang PL, Kedishvili NY, Grubbs CJ, Renfrow MB, Muccio DD, Elmets CA, Athar M..  (2022)  Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.,  65  (21.0): [PMID:36318154] [10.1021/acs.jmedchem.2c00735]

Source